My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 333

    1.

    Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects.

    Hermansen K, Søndergaard M, Høie L, Carstensen M, Brock B.

    Diabetes Care. 2001 Feb;24(2):228-33.PMID: 11213870 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes.

    Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL.

    Diabetes Care. 2002 Oct;25(10):1709-14.PMID: 12351466 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effects of soy supplementation on blood lipids and arterial function in hypercholesterolaemic subjects.

    Hermansen K, Hansen B, Jacobsen R, Clausen P, Dalgaard M, Dinesen B, Holst JJ, Pedersen E, Astrup A.

    Eur J Clin Nutr. 2005 Jul;59(7):843-50.PMID: 15900307 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of substituting dietary soybean protein and oil for milk protein and fat in subjects with hypercholesterolemia.

    Kurowska EM, Jordan J, Spence JD, Wetmore S, Piché LA, Radzikowski M, Dandona P, Carroll KK.

    Clin Invest Med. 1997 Jun;20(3):162-70.PMID: 9189647 [PubMed - indexed for MEDLINE]Related articles

    5.

    Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women.

    Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP.

    J Clin Endocrinol Metab. 2001 Jul;86(7):3053-60.PMID: 11443167 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes.

    Pipe EA, Gobert CP, Capes SE, Darlington GA, Lampe JW, Duncan AM.

    J Nutr. 2009 Sep;139(9):1700-6. Epub 2009 Jul 15.PMID: 19605528 [PubMed - indexed for MEDLINE]Related articles

    7.

    Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats.

    Dyrskog SE, Jeppesen PB, Colombo M, Abudula R, Hermansen K.

    Metabolism. 2005 Sep;54(9):1181-8.PMID: 16125530 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparison of the effects of a monounsaturated fat diet and a high carbohydrate diet on cardiovascular risk factors in first degree relatives to type-2 diabetic subjects.

    Thomsen C, Rasmussen O, Christiansen C, Pedersen E, Vesterlund M, Storm H, Ingerslev J, Hermansen K.

    Eur J Clin Nutr. 1999 Oct;53(10):818-23.PMID: 10556990 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of soy protein varying in isoflavone content on serum lipids in healthy young men.

    McVeigh BL, Dillingham BL, Lampe JW, Duncan AM.

    Am J Clin Nutr. 2006 Feb;83(2):244-51.PMID: 16469981 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.

    Navarro JF, Mora C, Muros M, García-Idoate G.

    Nephron Clin Pract. 2003;95(4):c128-35.PMID: 14694274 [PubMed - indexed for MEDLINE]Related articles

    11.

    Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production.

    Hall WL, Vafeiadou K, Hallund J, Bugel S, Reimann M, Koebnick C, Zunft HJ, Ferrari M, Branca F, Dadd T, Talbot D, Powell J, Minihane AM, Cassidy A, Nilsson M, Dahlman-Wright K, Gustafsson JA, Williams CM.

    Am J Clin Nutr. 2006 Mar;83(3):592-600.PMID: 16522905 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.

    Hernández-Mijares A, Lluch I, Vizcarra E, Martínez-Triguero ML, Ascaso JF, Carmena R.

    Nutr Metab Cardiovasc Dis. 2000 Feb;10(1):1-6.PMID: 10812581 [PubMed - indexed for MEDLINE]Related articles

    13.

    Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women.

    Wangen KE, Duncan AM, Xu X, Kurzer MS.

    Am J Clin Nutr. 2001 Feb;73(2):225-31.PMID: 11157317 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus.

    Moloney F, Yeow TP, Mullen A, Nolan JJ, Roche HM.

    Am J Clin Nutr. 2004 Oct;80(4):887-95.PMID: 15447895 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men.

    Kabir M, Oppert JM, Vidal H, Bruzzo F, Fiquet C, Wursch P, Slama G, Rizkalla SW.

    Metabolism. 2002 Jul;51(7):819-26.PMID: 12077724 [PubMed - indexed for MEDLINE]Related articles

    16.

    A double-blind placebo-controlled clinical trial compares the cholesterol-lowering effects of two different soy protein preparations in hypercholesterolemic subjects.

    Høie LH, Morgenstern EC, Gruenwald J, Graubaum HJ, Busch R, Lüder W, Zunft HJ.

    Eur J Nutr. 2005 Mar;44(2):65-71. Epub 2004 Apr 5.PMID: 15309422 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of soy protein containing isoflavones on blood lipids in moderately hypercholesterolemic adults: a randomized controlled trial.

    Ma Y, Chiriboga D, Olendzki BC, Nicolosi R, Merriam PA, Ockene IS.

    J Am Coll Nutr. 2005 Aug;24(4):275-85.PMID: 16093405 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.

    Azadbakht L, Shakerhosseini R, Atabak S, Jamshidian M, Mehrabi Y, Esmaill-Zadeh A.

    Eur J Clin Nutr. 2003 Oct;57(10):1292-4.PMID: 14506491 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.

    Dailey GE 3rd, Mohideen P, Fiedorek FT.

    Clin Ther. 2002 Sep;24(9):1426-38.PMID: 12380634 [PubMed - indexed for MEDLINE]Related articles

    20.

    The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.

    Diabetes Atorvastin Lipid Intervention (DALI) Study Group.

    Diabetes Care. 2001 Aug;24(8):1335-41.PMID: 11473066 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity